Breaking New York City’s “Pied-à-terre” Tax Sparks Debate and Legal Challenges Google Unveils New Pixel Phones With Advanced AI and Enhanced Camera Features Key 2026 College Football Matchups Poised to Shape Playoff Picture Severe Weather Causes Fatalities and Widespread Power Outages Across Midwest Five Car Models Slated for Discontinuation After 2026 Model Year, Edmunds Reports

Wednesday August 12, 2026

Reporter

Kye Pharmaceuticals Inc.

1Articles Published

4Communities Covered

Published Articles

Press Release

SLENYTO® (melatonin extended-release tablets) is now available in Canada as a prescription treatment for insomnia in children and adolescents with autism spectrum disorder (ASD) and/or Smith-Magenis syndrome (SMS).

Aug 11